Tradestie Institutional Equity Comparison Engine

ARKG vs ARKQ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ARKG Overall Edge

ARKG Captures Institutional Edge (1โ€“1 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ARK Genomic Revolution ETF (ARKG) driven by superior Momentum & Technical while ARKQ counters with relative strength in Options & Structure. Fundamentally, ARKG trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ARKQ at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ARKG sits in UNCLASSIFIED (38th %ile IV; Dealer Gamma Walls on Pro) against ARKQ sits in UNCLASSIFIED (1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ARKG N/M vs ARKQ N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner ARKG
1Y +51.3% vs -4.5% ยท 52W Pos 48% vs 11%
Options & Structure Winner ARKQ
UNCLASSIFIED (38th %ile IV) vs UNCLASSIFIED (1st %ile IV)
ARKG Cboe BZX
ARK Genomic Revolution ETF
Institutional Equity
$40.92
-5.28% 1D
Market Cap N/A
1M Return -12.38%
1Y Return +51.33%
Forward P/E N/M
Unified AI Score
48.6 / 100 HOLD
Tech 26.0 Fund 45.0 Flow 50.0 Mom 68.9
ARKQ Cboe BZX
ARK Autonomous Technology & Robotics ETF
Institutional Equity
$103.43
-4.14% 1D
Market Cap N/A
1M Return -7.85%
1Y Return -4.55%
Forward P/E N/M
Unified AI Score
47.8 / 100 HOLD
Tech 48.0 Fund 51.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ARKG +51.33% ARKQ -4.55% Spread: +55.88 pp (ARKG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ARKG TTM Op. Margin: N/A ARKQ TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARKG vs ARKQ. Trailing 12-month operating profitability (ARKG N/A vs ARKQ N/A) and valuation multiples (ARKG N/M vs ARKQ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ARKG (2) vs ARKQ (1)
Institutional Metric ARKG ARKQ Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 48% ($25โ€“$59) 11% ($98โ€“$144) Stronger Trend ARKG
Beta / 30D Volatility Risk Regime 2.08ฮฒ ยท 70% Vol 2.11ฮฒ ยท 49% Vol Lower Realized Risk ARKQ
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 47.8 / 100 (HOLD) Higher Composite ARKG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ARKG vs ARKQ Buy Guide
ARKG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ARKG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARKQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 1st %ile
IV Regime Compressed (<25th %ile)
Live ARKQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ARKG nor ARKQ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.